Neuropathy
Common Issues in Breast Cancer Survivors: A Practical Guide to Evaluation and Management, Page: 121-138
2021
- 10Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures10
- Readers10
- 10
Book Chapter Description
Peripheral neuropathy is commonly seen in breast cancer patients both actively receiving care and breast cancer survivors. Both short-term and long-term neuropathy can have a profound impact on quality of life during survivorship. Surgical and systemic treatments can cause neuropathy. Mastectomy can be complicated by the development of post-mastectomy pain syndrome and/or persistent post-mastectomy pain. Chemotherapy-induced peripheral neuropathy is common following treatment with chemotherapies used within the breast cancer setting. This chapter will review both surgical and systemic origins of neuropathy, identify risk factors, and review prevention and treatment modalities.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85169393975&origin=inward; http://dx.doi.org/10.1007/978-3-030-75377-1_8; https://link.springer.com/10.1007/978-3-030-75377-1_8; https://link.springer.com/content/pdf/10.1007/978-3-030-75377-1_8; https://dx.doi.org/10.1007/978-3-030-75377-1_8; https://link.springer.com/chapter/10.1007/978-3-030-75377-1_8
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know